Biomanufacturers should follow a risk-based approach to decide which methods to use to characterize their products.
Lisa Crossley, PhD
Advertisement
Lisa Crossley, PhD, is the founder and principal of BioVentures, Ontario, Canada, 888.405.9549.
Articles by Lisa Crossley, PhD
Advertisement
Latest Updated Articles
Protein Characterization Through the StagesAugust 2nd 2010
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
2
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
3
Wave Reports 1-Year INLIGHT Data for INHBE siRNA WVE-007 in Obesity
4
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
5